1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
IntegraDose Compounding Services LLC recalled 853 bags of Oxytocin 30 Units/500 mL on September 16, 2025. Testing revealed these IV bags contain no oxytocin, posing serious health risks. The recall affects products distributed nationwide in the USA.
Abiomed recalled 9,177 Automated Impella Controllers on September 16, 2025. The recall follows reports of purge pressure issues due to purge retainer failures. Patients and healthcare providers must stop using the devices immediately.
Graviti Pharmaceuticals recalled 46,512 bottles of Bupropion Hydrochloride Extended-Release Tablets on September 15, 2025. The recall stems from failed tablet specifications that could affect safety and efficacy. The product was distributed to pharmacies nationwide.
Alcon Research LLC recalled 28,323 CONSTELLATION ULTRAVIT and HYPERVIT devices on September 15, 2025, due to a high hazard risk. The recall affects products distributed worldwide, including multiple states in the U.S. and several countries.
American Health Packaging recalled 360 cartons of Carbamazepine Extended-Release Tablets on September 15, 2025. The tablets fail to meet dissolution specifications, posing a risk to patients. Consumers should stop using the product immediately and consult healthcare providers for guidance.
FUJIFILM Healthcare Americas recalled 16 units of the CH-200 X-ray tube support on September 15, 2025, due to a potential shaft failure. The broken shaft could render protective components ineffective, posing a high risk during operation. Healthcare providers and patients must stop using the device immediately.
Private Label Skin Care recalled its 7 oz Acne Treatment on September 12, 2025. Elevated levels of benzene prompted the recall, classified as Class II. The affected product was distributed in California and Georgia only.
Private Label Skin Care recalled 125 units of ARTISAN OF SKIN Benzoyl Peroxide 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers should stop using the product immediately and seek guidance.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its edunn clarity BP Treatment Cleanser on September 12, 2025. Elevated benzene levels prompted the recall after post-consumer awareness. The product was distributed in California and Georgia.
Private Label Skin Care recalled Benzaderm BPO Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall affecting consumers in California and Georgia. No injuries have been reported.
Unique Pharmaceuticals Labs recalled 9,936 bottles of Cetirizine Hydrochloride Tablets on September 12, 2025. The tablets were imprinted with the wrong ID, posing a potential health risk. Consumers should stop using the product immediately and seek guidance from healthcare providers.
GE HealthCare recalled 37 nuclear medicine gamma cameras on September 12, 2025. The recall follows concerns that inadequate detector support during transport could lead to life-threatening falls. The affected systems are past the End of Guaranteed Service and pose serious risks to patients and healthcare providers.
Diagnostica Stago recalled 12,740 D-Dimer testing devices on September 12, 2025. The recall follows a risk of underestimating D-Dimer levels in patients. Healthcare providers and patients should stop using the device immediately.
GE HealthCare recalled 45 dual-head nuclear medicine gamma cameras on September 12, 2025. The recall affects devices that may have been relocated without proper support, risking a detector fall. This defect can lead to life-threatening injuries.
Shanghai United Imaging Healthcare Co., Ltd. recalled 22 units of its uCT 550 MD X-ray system on September 12, 2025. The recall was issued after reports that third-party outer covers can trap between the patient table and gantry. This can cause mechanical interference during table movement, posing a high risk to patients and healthcare providers.
Shanghai United Imaging Healthcare Co., Ltd. recalled two units of its uCT 780 MD Computed Tomography X-ray System on September 12, 2025. Third-party outer covers can trap between the patient table and gantry, causing mechanical interference. This recall affects units distributed in the US and internationally.
Shanghai United Imaging Healthcare Co., Ltd. recalled 11 units of its uCT 760 MD Computed Tomography X-ray System on September 12, 2025. The recall addresses a serious hazard where third-party outer covers can become trapped between the patient table and gantry, leading to mechanical interference. Healthcare providers and patients must stop using the device immediately and follow recall directives
UIH Technologies recalled two units of the uEXPLORER MD system on September 12, 2025. Third-party covers can trap between the patient table and gantry, causing mechanical interference. Healthcare providers must stop using the device immediately and follow recall instructions.
GE HealthCare recalled 292 nuclear medicine gamma cameras on September 12, 2025. The devices may have been relocated without proper support, risking detector falls. This poses a serious risk of life-threatening injuries.
GE HealthCare recalled 11 Cardial nuclear medicine gamma cameras on September 12, 2025. The recall follows concerns over inadequate detector support potentially leading to life-threatening falls. The affected systems were transported without proper safeguards, compromising safety.
GE HealthCare recalled 1,386 nuclear medicine gamma cameras on September 12, 2025. Certain models may have been relocated without proper support, risking detector integrity. This could lead to life-threatening injuries from falls.
Major Pharmaceuticals recalled 866 blister packs of Chlorpromazine Hydrochloride Tablets on September 12, 2025. The recall follows the detection of N-Nitroso Desmethyl Chlorpromazine above safe limits. The affected products were distributed nationwide and are classified as a Class II hazard.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.